With publicly available data sets, we found expression profiling of high Embigin (gene name: EMB) or low p21WAF1 (gene name: CDKN1A) mRNA in prostate cancer patients [33,34], which leads to worse overall survival (Figure 8A,B). Here, CDKN1A is linked to prostate carcinoma.